China Resources Double-Crane: Full subsidiary Glycerol Injection receives approval notice for supplementary drug application

MetaMuskRat · 2026-04-08T20:30:47+00:00

People's Financial News, April 7 — China Resources Double Crane (600062) announced on April 7 that its wholly-owned subsidiary, Jingxi Double Crane, received the "Notice of Approval for the Supplementary Application of the Drug" from the National Medical Products Administration for Mannitol Injection. Mannitol Injection (3000ml:150g) is used as a rinse agent for intraurethral surgical irrigation to maintain a clear view.

MetaMuskRat

2026-04-08 20:30:47

People Finance News, April 7. China Resources Shuanghe (600062) announced on April 7 that its wholly owned subsidiary, Jingxi Shuanghe, received from the National Medical Products Administration a “Notice of Approval for a Drug Supplementary Application” for Mannitol Injection. Mannitol Injection (3000ml:150g), as an irrigation agent, is used to irrigate the surgical area via the urethra for transurethral intracavitary surgery to keep the field of view clear.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.